company background image
ALMD

Median Technologies ENXTPA:ALMDT Stock Report

Last Price

€11.10

Market Cap

€171.7m

7D

3.9%

1Y

-24.5%

Updated

23 May, 2022

Data

Company Financials +
ALMDT fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health5/6
Dividends0/6

ALMDT Stock Overview

Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally.

Median Technologies Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for Median Technologies
Historical stock prices
Current Share Price€11.10
52 Week High€18.32
52 Week Low€9.30
Beta2.38
1 Month Change-11.91%
3 Month Change-7.19%
1 Year Change-24.49%
3 Year Change780.95%
5 Year Change-7.03%
Change since IPO10.12%

Recent News & Updates

May 07
Is Median Technologies (EPA:ALMDT) Using Too Much Debt?

Is Median Technologies (EPA:ALMDT) Using Too Much Debt?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Shareholder Returns

ALMDTFR Healthcare ServicesFR Market
7D3.9%2.9%-1.5%
1Y-24.5%-9.2%-18.8%

Return vs Industry: ALMDT underperformed the French Healthcare Services industry which returned -12% over the past year.

Return vs Market: ALMDT underperformed the French Market which returned -5.4% over the past year.

Price Volatility

Is ALMDT's price volatile compared to industry and market?
ALMDT volatility
ALMDT Average Weekly Movement9.3%
Healthcare Services Industry Average Movement7.4%
Market Average Movement6.0%
10% most volatile stocks in FR Market10.2%
10% least volatile stocks in FR Market3.5%

Stable Share Price: ALMDT is more volatile than 75% of French stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: ALMDT's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of French stocks.

About the Company

FoundedEmployeesCEOWebsite
2002186Fredrik Braghttps://www.mediantechnologies.com

Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iBiops, an end-to-end AI-powered technology software as a medical device that integrates and optimizes the entire medical imaging workflow; and iSee for image analysis services in clinical trials. It also provides imaging contract research services, such as study start up, image and clinical data management, scientific consulting, independent reviews, image data processing and site support, and study close-out for studies.

Median Technologies Fundamentals Summary

How do Median Technologies's earnings and revenue compare to its market cap?
ALMDT fundamental statistics
Market Cap€171.71m
Earnings (TTM)-€19.29m
Revenue (TTM)€20.75m

8.3x

P/S Ratio

-8.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ALMDT income statement (TTM)
Revenue€20.75m
Cost of Revenue€17.80m
Gross Profit€2.95m
Other Expenses€22.24m
Earnings-€19.29m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-1.25
Gross Margin14.21%
Net Profit Margin-92.99%
Debt/Equity Ratio316.8%

How did ALMDT perform over the long term?

See historical performance and comparison

Valuation

Is Median Technologies undervalued compared to its fair value and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


34.77x

Price to Book (PB) ratio

Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate ALMDT's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate ALMDT's fair value for valuation analysis.


Price To Earnings Ratio

PE vs Industry: ALMDT is unprofitable, so we can't compare its PE Ratio to the European Healthcare Services industry average.

PE vs Market: ALMDT is unprofitable, so we can't compare its PE Ratio to the French market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate ALMDT's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: ALMDT is overvalued based on its PB Ratio (34.8x) compared to the FR Healthcare Services industry average (2.6x).


Future Growth

How is Median Technologies forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

Future Growth Score

2/6

Future Growth Score 2/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


53.2%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: ALMDT is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: ALMDT is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: ALMDT is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: ALMDT's revenue (31.4% per year) is forecast to grow faster than the French market (5.8% per year).

High Growth Revenue: ALMDT's revenue (31.4% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if ALMDT's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Median Technologies performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-1.8%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: ALMDT is currently unprofitable.

Growing Profit Margin: ALMDT is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: ALMDT is unprofitable, and losses have increased over the past 5 years at a rate of 1.8% per year.

Accelerating Growth: Unable to compare ALMDT's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ALMDT is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-3%).


Return on Equity

High ROE: ALMDT has a negative Return on Equity (-390.68%), as it is currently unprofitable.


Financial Health

How is Median Technologies's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: ALMDT's short term assets (€47.5M) exceed its short term liabilities (€27.3M).

Long Term Liabilities: ALMDT's short term assets (€47.5M) exceed its long term liabilities (€17.2M).


Debt to Equity History and Analysis

Debt Level: ALMDT has more cash than its total debt.

Reducing Debt: ALMDT's debt to equity ratio has increased from 1.2% to 316.8% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ALMDT has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: ALMDT has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 1.1% each year


Dividend

What is Median Technologies's current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate ALMDT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ALMDT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ALMDT's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ALMDT's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as ALMDT has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

3.5yrs

Average management tenure


CEO

Fredrik Brag

20.33yrs

Tenure

€498,000

Compensation

Mr. Fredrik Brag founded Median Technologies S.A. in 2002 and served as its Chairman and President until April 2019 and serves as its Chief Executive Officer and General Manager. Mr. Brag has been Director...


CEO Compensation Analysis

Compensation vs Market: Insufficient data to establish whether Fredrik's total compensation is reasonable compared to companies of similar size in the French market.

Compensation vs Earnings: Fredrik's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: ALMDT's management team is considered experienced (3.5 years average tenure).


Board Members

Experienced Board: ALMDT's board of directors are considered experienced (6.5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5.5%.


Top Shareholders

Company Information

Median Technologies SA's employee growth, exchange listings and data sources


Key Information

  • Name: Median Technologies SA
  • Ticker: ALMDT
  • Exchange: ENXTPA
  • Founded: 2002
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Implied Market Cap: €171.714m
  • Shares outstanding: 15.47m
  • Website: https://www.mediantechnologies.com

Number of Employees


Location

  • Median Technologies SA
  • 1800, Route des Crêtes
  • Valbonne
  • Provence-Alpes-Côte d'Azur
  • 6560
  • France

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/23 00:00
End of Day Share Price2022/05/23 00:00
Earnings2021/12/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.